Guide to Diabetes Treatment Options: A Clinical Overview

This guide to diabetes treatment options explains the major approaches used to manage type 1 diabetes, type 2 diabetes, and related risks. Treatment commonly combines nutrition, physical activity, glucose monitoring, medicines, and preventive care, with decisions tailored to the individual rather than applied as a single standard plan. 1

Foundations of Diabetes Treatment

Diabetes care begins with a plan for blood glucose, blood pressure, cholesterol, weight, sleep, stress, and tobacco exposure. The National Institute of Diabetes and Digestive and Kidney Diseases describes these priorities as the diabetes ABCs, noting that managing them can reduce the likelihood of heart attack, stroke, kidney disease, blindness, and amputation. For many adults, an A1C goal below 7% is used, although the appropriate target varies with health conditions and treatment risks. 5

Lifestyle measures remain part of treatment even when medication is required. Healthy eating patterns, regular physical activity, adequate sleep, and stress management can support glucose control, while smoking cessation can reduce cardiovascular risk. The Diabetes Prevention Program found that intensive lifestyle intervention reduced progression from prediabetes to type 2 diabetes by 58% in high-risk adults. 17

Type 1 Diabetes and Insulin Replacement

Type 1 diabetes occurs when the pancreas does not produce the insulin needed to regulate glucose. Insulin replacement is therefore essential, and treatment generally involves multiple doses during the day, including doses related to meals and beverages. Delivery methods include a needle and syringe, an insulin pen, or an insulin pump. An automated insulin delivery system may be appropriate for some people. 1

Automated insulin delivery combines a continuous glucose monitor, an insulin pump, and a computer algorithm that adjusts insulin in response to sensor readings. Mayo Clinic describes this as the current leading treatment approach for many people with type 1 diabetes, while noting that users still enter meal carbohydrate information. Continuous glucose data also show changing patterns that a single daily measurement or A1C result may not capture. 2

Type 2 Diabetes Medication Choices

Type 2 diabetes treatment often combines weight management, meal planning, physical activity, glucose monitoring, and medication. Metformin lowers the amount of glucose made and released by the liver, while other medicines act through different pathways. Common categories include sulfonylureas, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, and insulin. More than one medicine may be used when one treatment does not provide adequate control. 6

Medication selection increasingly considers conditions beyond glucose levels. Clinical guidance identifies cardiovascular disease, heart failure, chronic kidney disease, obesity, treatment burden, cost, adherence, and hypoglycemia risk as relevant factors. Some GLP-1 and dual GIP/GLP-1 medicines, as well as SGLT2 inhibitors, may be selected for benefits connected with cardiovascular, kidney, weight, or metabolic concerns, depending on the person’s clinical profile and eligibility. 7

Insulin and Non-Insulin Injectables

Insulin can be used in type 2 diabetes when glucose levels remain high despite other measures, when the pancreas produces insufficient insulin, or during particular medical circumstances. It is usually injected under the skin through syringes, pens, or pumps. Inhaled insulin exists for certain situations but is not commonly used. Insulin cannot generally be taken as a conventional oral tablet because digestion interferes with its action. 4

Non-insulin injectable medicines include GLP-1 receptor agonists and medicines combining glucose-dependent insulinotropic polypeptide with GLP-1 activity. These treatments differ from insulin in their mechanisms and dosing considerations. Potential adverse effects, contraindications, kidney function, interactions, body-weight goals, and personal ability to follow the regimen must be reviewed by a healthcare professional before selection. 3

Glucose Monitoring and Treatment Technology

Continuous glucose monitors use a sensor to provide repeated glucose information from interstitial fluid. The resulting readings can reveal trends, changes after meals, and periods of low or high glucose, helping patients and clinicians evaluate whether a treatment plan is working. The Food and Drug Administration describes these systems as devices that provide glucose information to support diabetes management, but they do not eliminate the need for appropriate clinical interpretation. 10

Insulin pumps deliver insulin through a wearable device, while automated systems connect pump delivery with continuous glucose data and an algorithm. Technology may reduce some daily treatment tasks, but it still requires sensor replacement, device maintenance, alert response, supply access, and technical training. For people using insulin, a backup plan for equipment problems and unexplained high glucose should be established with the diabetes care team. 14

Safety, Surgery, and Long-Term Monitoring

Hypoglycemia is a central safety concern because insulin and some medicines that increase insulin release can lower glucose excessively. People at risk may need education about warning signs, fast-acting carbohydrates, medication adjustments, and glucagon when prescribed. Medicines should not be stopped or doses changed without professional guidance, because glucose can rise substantially or treatment complications can occur. 6

Metabolic or bariatric surgery is another option for selected adults with obesity and type 2 diabetes and can produce substantial weight loss with major improvement, or sometimes remission, of diabetes. Eligibility depends on clinical factors and requires continuing follow-up. Long-term diabetes care also includes kidney testing, blood-pressure and cholesterol management, eye examinations, foot care, and recommended vaccinations. Diabetic retinopathy may develop before noticeable vision changes, making regular eye examinations important. 16 18

Sources

1. National Institute of Diabetes and Digestive and Kidney Diseases, Insulin, Medicines, & Other Diabetes Treatments
2. Mayo Clinic, Diabetes Diagnosis and Treatment
3. Cleveland Clinic, Diabetes Medications
4. Merck Manual Professional Edition, Medications for Diabetes Mellitus Treatment
5. National Institute of Diabetes and Digestive and Kidney Diseases, Managing Diabetes
6. American Heart Association, Diabetes Medications
7. NCBI Bookshelf Endotext, Management of Type 2 Diabetes
8. American Diabetes Association, Standards of Care in Diabetes 2026
9. Centers for Disease Control and Prevention, Diabetes Overview
10. U.S. Food and Drug Administration, Continuous Glucose Monitoring
11. MedlinePlus, Diabetes Medicines
12. Centers for Medicare & Medicaid Services, Medicare Diabetes Prevention Program
13. Mayo Clinic, Type 2 Diabetes Diagnosis and Treatment
14. Cleveland Clinic, Insulin
15. Johns Hopkins Medicine, Continuous Glucose Monitoring
16. NCBI Bookshelf StatPearls, Metabolic Surgery
17. National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes Prevention Program
18. National Eye Institute, Diabetic Retinopathy